Foote Robert L, Weidner Noel, Harris Jonathan, Hammond Elizabeth, Lewis Jean E, Vuong Te, Ang K Kian, Fu Karen K
Division of Radiation Oncology, Mayo Clinic College of Medicine, Rochester, MN 55905, USA.
Int J Radiat Oncol Biol Phys. 2005 Mar 1;61(3):745-53. doi: 10.1016/j.ijrobp.2004.07.694.
The objective of this study was to evaluate tumor angiogenesis as measured by microvessel density (MVD) as an independent prognostic factor in patients with nasopharyngeal carcinoma (NPC) treated with radiotherapy alone.
Eligible patients included those with NPC treated with radiotherapy. Paraffin blocks of the primary tumor had a hematoxylin and eosin-stained section prepared at the block face. One representative section for tumor was stained for factor VIII-related antigen using a standard immunoperoxidase staining technique. MVD was determined by light microscopy in areas of invasive tumor containing the highest numbers of capillaries and microvessels per area. Individual microvessel counts were made on a 200x field within the area of most intense tumor neovascularization. Results were expressed as the highest number of microvessels identified within any single 200x field. Using a breakpoint of MVD <60 vs. > or =60, the distributions between the two MVD groups were compared by the method of Gray. Overall survival rates were estimated by the Kaplan-Meier method and compared by the log-rank test. A multivariate Cox proportional hazard model was employed to examine the relationship between MVD and disease outcomes while adjusting for other concomitant variables.
One hundred sixty-six were eligible, of whom 123 had values determined for MVD. The MVD values ranged from 9 to 243 with a median of 70. In the multivariate analysis of overall survival, distant metastases, and local-regional failure, MVD did not significantly improve the model containing T stage, N stage, age, radiation dose, and World Health Organization class.
We found no significant differences in overall survival, time to distant metastasis, or time to local-regional failure using a breakpoint of MVD <60 vs. MVD > or =60. The study was perhaps limited by the small size of the NPC samples.
本研究的目的是评估通过微血管密度(MVD)测量的肿瘤血管生成情况,将其作为单纯接受放疗的鼻咽癌(NPC)患者的独立预后因素。
符合条件的患者包括接受放疗的NPC患者。原发肿瘤的石蜡块在块面制备苏木精和伊红染色切片。使用标准免疫过氧化物酶染色技术对肿瘤的一张代表性切片进行VIII因子相关抗原染色。通过光学显微镜在每单位面积毛细血管和微血管数量最多的浸润性肿瘤区域测定MVD。在肿瘤新生血管最密集区域的200倍视野内进行单个微血管计数。结果表示为在任何单个200倍视野内识别出的微血管最高数量。使用MVD<60与≥60的断点,通过Gray方法比较两个MVD组之间的分布。采用Kaplan-Meier方法估计总生存率,并通过对数秩检验进行比较。采用多变量Cox比例风险模型在调整其他伴随变量的同时检查MVD与疾病结局之间的关系。
166例符合条件,其中123例测定了MVD值。MVD值范围为9至243,中位数为70。在总生存、远处转移和局部区域失败的多变量分析中,MVD并未显著改善包含T分期、N分期、年龄、放射剂量和世界卫生组织分级的模型。
我们发现,使用MVD<60与MVD≥60的断点,在总生存、远处转移时间或局部区域失败时间方面没有显著差异。该研究可能受NPC样本量小的限制。